Fairvalue-Calculator Fairvalue-Calculator
EN DE

Matvareexpressen AS (MVE) Fair Value & Analysis

Consumer Cyclical · NO · Market cap 262M NOK

Pricekr 264.00
Fair Valuekr 70.72
Upside-73.2%
Quality95/100
Evidence: Medium Range kr 53.04 – kr 88.40

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Matvareexpressen AS (MVE) currently trades at kr 264.00, while our model-based Fair Value estimate is kr 70.72 — implying the stock looks roughly 73.2% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Matvareexpressen AS engages in the online sale of groceries and household products in Norway. The company was founded in 2007 and is headquartered in Haugesund, Norway.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Matvareexpressen AS (MVE) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 70.72 versus a price of kr 264.00 — about −73% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MVE?
Our 21-model fair value for Matvareexpressen AS is kr 70.72 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 264.00.
What is the quality score of MVE?
Matvareexpressen AS has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.